A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol.
Benjamin Andreas BerkRowena Mary Anne PackerTsz Hong LawAnnette WessmannAndrea Bathen-NöthenTarja Susanna JokinenAnna KnebelAndrea TipoldLudovic PelligandHolger Andreas VolkPublished in: BMC veterinary research (2019)
Dietary interventions are rarely studied in a standardised form in veterinary medicine. The background diet, the cohort of animals and ASD received is standardised in this prospective diet trial to ensure representative data about the potential effect of MCT DS. If the study data confirms former findings, this would provide further evidence for the efficacy of MCTs as a management option for canine epilepsy. This publication should offer a repository of trial conditions and variable description with forecasted statistical analysis.
Keyphrases
- study protocol
- open label
- clinical trial
- phase iii
- randomized controlled trial
- phase ii
- physical activity
- placebo controlled
- double blind
- fatty acid
- electronic health record
- weight loss
- autism spectrum disorder
- big data
- attention deficit hyperactivity disorder
- cross sectional
- machine learning
- intellectual disability
- risk assessment